Polysaccharide microneedles and 3D printing explored for cancer immunotherapy applications

Researchers have reviewed the use of polysaccharide-based microneedles (PMNs) for cancer immunotherapy, examining how additive manufacturing methods, including 3D printing, can support the development of transdermal drug delivery systems. The study, published in Glycoscience & Therapy, focuses…

This story was originally published by 3D Printing Industry.